- Uppsala, Sweden-based Orexo developed a low dose version of its opioid dependence treatment Zubsolv.
- The Mi-eye 2 is a second-generation diagnostic device used to diagnose and treat joint injuries.
- BurstDR is a physician-developed form of spinal cord stimulation used to treat patients with chronic pain.
- Jerusalem-based Teva Pharmaceutical Industries developed abacavir and lamivudine tablets to treat adults with HIV-1 infection.
More articles on supply chain:
FedEx to open new Ohio distribution center in 2017
Insmed buys AstraZeneca’s respiratory drug for $150M: 5 things to know
Novartis restructures research unit, sheds 175 jobs: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
